Skip to main content

Table 1 Characteristics of the cohort of patients

From: Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies

 

Total sample

Health care proxy

Advance directives

   

Yes

No

N/A

Yes

No

N/A

 

n.

%

n.

%

n.

%

n.

%

n.

%

n.

%

n.

%

Year medical records were studied

             

2008-2009

60

30.5

35

58.3

14

23.3

11

18.3

3

5.0

34

56.7

23

38.3

2010

54

27.4

38

70.4

10

18.5

6

11.1

4

7.4

34

63.0

16

29.6

2011-2012

83

42.1

54

65.1

14

16.9

15

18.1

5

6.0

52

62.7

26

31.3

Population

197

100.0

127

64.5

38

19.3

32

16.2

12

6.1

120

60.9

65

33.0

Gender

              

Male

110

55.8

71

64.5

21

19.1

18

16.4

6

5.5

72

65.5

32

29.1

Female

87

44.2

56

64.4

17

19.5

14

16.1

6

6.9

48

55.2

33

37.9

Sex ratio

1.26

1.27

1

Age groups on diagnosis

             

<70

124

63.0

79

63.7

27

21.8

18

14.5

5

4.0

83

66.9

36

29.0

≥70

73

37.0

48

65.8

11

15.1

14

19.2

7

9.6

37

50.7

29

39.7

Median age (years)

66

67

73

Average age (years) SD (min-max)

64.4 ± 15.8 [18;91]

64.8 ± 14.2 [23;91]

72.5 ± 5.6 [62;83]

Marital status

              

Married or with a partner

138

70.1

98

71.0

24

17.4

16

11.6

9

6.5

87

63.0

42

30.4

Single/Widowed

44

22.3

19

43.2

11

25.0

14

31.8

3

6.8

22

50.0

19

43.2

Not filled in

15

7.6

10

66.7

3

20.0

2

13.3

-

-

11

73.3

4

26.7

Pathologies

              

Lymphoid pathologies1

136

69.0

91

66.9

26

19.1

19

14.0

4

2.9

81

59.6

51

37.5

Myeloid pathologies and others2

61

31.0

36

59.0

12

19.7

13

21.3

8

13.1

39

63.9

14

23.0

Wish to meet a religious representative

            
 

16

8.1

12

75.0

1

6.3

3

18.8

6

37.5

9

56.3

1

6.3

Wish to meet a volunteer

             
 

9

4.6

6

66.7

1

11.1

2

22.2

3

33.3

5

55.6

1

11.1

  1. 1Lymphoid pathologies: NHL, Hodgkin’s disease, Hairy cell leukaemia, myeloma, amyloidosis, Waldenstrom’s disease, CLL).
  2. 2Myeloid pathologies and others: acute leukaemia and myelodysplasia (RAEB), CMML, myeloproliferative disorders (CML, primary myelofibrosis, essential thrombocythemia, polycythemia vera, rare non malignant haemopathies (aplastic anemia, severe autoimmune cytopenias, thrombotic microangiopathies, immune deficiencies.